ALNYLAM ANNOUNCES HEALTH CANADA APPROVAL OF AMVUTTRA® (VUTRISIRAN), THE FIRST AND ONLY RNAI THERAPEUTIC FOR THE TREATMENT OF CARDIOMYOPATHY IN ADULT PATIENTS WITH ATTR AMYLOIDOSIS

Reuters · 21h ago

Please log in to view news